RxDoctor Payments Data

John Coleman, MD

Otolaryngology · Atlanta, GANPI 1902854060

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $988, 2.6 times the $386 reported in 2019.

$3,794in general payments, 2019–2025

Across 156 payments — averaging $24.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$638
  • Sanofi$516
  • Merz North America, Inc.$458
  • Optinose US, Inc.$367
  • AbbVie$313
  • GSK$276
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,76099%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,794 in reported general payments places this provider in the 80th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$120,854
Medicare patients
463
Services billed
2,500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl417$11,659
Fluticasone Propionate374$4,228
Azelastine-FluticasoneAzelastine/Fluticasone30$2,321
Ipratropium Bromide64$2,179
Famotidine122$880
CefuroximeCefuroxime Axetil32$714
Nystatin26$669
Montelukast Sodium60$640
Mupirocin88$491
Levocetirizine Dihydrochloride31$303
Omeprazole24$257
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$108
Prednisone35$100
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$88
Cephalexin12$59

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →